NDC 60505-0223-01 - Sotalol Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-0223
- Requested NDC
- 60505-0223-01
- Package NDCs from labels
- 60505-0223-1, 60505-0223-2, 60505-0223-01
- Manufacturer
- Apotex Corp. | Apotex Inc.
- Effective date
- 2026-09-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sotalol Hydrochloride - Apotex Corp. | Apotex Inc. | Apotex Corp. | Apotex Inc. | 2026-09-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-0223-1 | Sotalol Hydrochloride | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 17 | |
| 60505-0223-2 | Sotalol Hydrochloride | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 17 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-0223 | SOTALOL HYDROCHLORIDE TABLET [APOTEX CORP.] | 16 | Current NDC, Legacy NDC, 2 package rows | 20241003_1a56c82e-7ecd-43b0-2899-f89e47adf7db.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-0223-1 | EA - Each | 60505-0223 | b4c7896e-f0b6-46ac-8924-e31ca7a568bd | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| SOTALOL HYDROCHLORIDE | ACTIVE INGREDIENT | HEC37C70XX | SOTALOL HYDROCHLORIDE TABLET [APOTEX CORP.] | 8 | |
| SOTALOL | ACTIVE MOIETY | A6D97U294I | SOTALOL HYDROCHLORIDE TABLET [APOTEX CORP.] | 8 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | SOTALOL HYDROCHLORIDE TABLET [APOTEX CORP.] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | SOTALOL HYDROCHLORIDE TABLET [APOTEX CORP.] | 8 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sotalol Hydrochloride | SOTALOL HYDROCHLORIDE | Bryant Ranch Prepack | f8d0daf3-5eab-44f1-9dec-40e5d9c2bbcf | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | 1923424 HEC37C70XX |
| Sotalol Hydrochloride | SOTALOL HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 8e2772cb-7dea-42d1-ba31-d479ba7cb09a | 2023-12-01 | Boxed warning, Warnings, Adverse reactions | 1923424 904589 1923422 1923426 HEC37C70XX |
| Sotalol Hydrochloride | SOTALOL HYDROCHLORIDE | Bryant Ranch Prepack | 2f13a6dd-dd77-47c8-ac5d-4a746c32dbd0 | 2023-11-06 | Boxed warning, Warnings, Adverse reactions | 1923426 HEC37C70XX |
| Sotalol Hydrochloride | SOTALOL HYDROCHLORIDE | Oxford Pharmaceuticals, LLC | c8ac6351-b1e9-4dd2-82f2-5980814fda15 | 2023-11-02 | Boxed warning, Warnings, Adverse reactions | 1923424 904589 1923422 1923426 HEC37C70XX |
| Sotalol Hydrochloride | SOTALOL HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 5e005309-4eca-4536-8743-c6ed9e5b3195 | 2023-08-08 | Boxed warning, Warnings, Adverse reactions | ANDA076140 1923426 HEC37C70XX |
| Sotalol Hydrochloride | SOTALOL HYDROCHLORIDE | Proficient Rx LP | 517824b1-11be-40a9-9066-d1a6a32a2938 | 2023-07-01 | Boxed warning, Warnings, Adverse reactions | ANDA076140 1923426 HEC37C70XX |
| Sotalol Hydrochloride | SOTALOL HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 253da1e1-022a-4175-bd7f-e7673cba0767 | 2022-02-22 | Boxed warning, Warnings, Adverse reactions | 1923426 HEC37C70XX |
| Sotalol Hydrochloride | SOTALOL HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 5ede17b7-3898-4f9f-abec-e15620cef76a | 2018-06-26 | Boxed warning, Warnings, Adverse reactions | ANDA076214 1922765 HEC37C70XX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.